Intuitive Surgical insider sale: 3,500 shares via 10b5-1 plan

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) reported insider activity by EVP & Chief Digital Officer Brian Miller. On 11/10/2025, he exercised options for 1,298 shares at $229.39 and 2,202 shares at $208.90, then sold the same 3,500 shares at $575.00 per share under a Rule 10b5-1 trading plan that expires on December 10, 2025. Following these transactions, he directly owned 5,758 common shares. Remaining derivative holdings included 2,115 and 6,602 non-qualified stock options from prior grants, subject to stated vesting schedules.

Insider Trade Summary

Exercise and Sale: 3,500 shares ($1.25M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Miller Brian Edward

Role EVP & Chief Digital Officer

Sold 3,500 shs ($2.01M)

Approx. gross sale proceeds $2.01M

Approx. exercise cost $758K

Approx. pre-tax spread $1.25M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	2,202	$0.00	$0.00
Exercise	Non-Qualified Stock Option (right to buy)	1,298	$0.00	$0.00
Exercise	Common Stock	1,298	$229.39	$298K
Sale	Common Stock	1,298	$575.00	$746K
Exercise	Common Stock	2,202	$208.90	$460K
Sale	Common Stock	2,202	$575.00	$1.27M

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 8,717 shares (Direct); Common Stock — 5,758 shares (Direct)

Footnotes (3)

1. F1. These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025.
2. F2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
3. F3. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/12/2025 - 02:03 PM Learn about SEC filing dates

FAQ

What did ISRG’s EVP Brian Miller do on 11/10/2025?

He exercised options for 1,298 and 2,202 shares, then sold a total of 3,500 shares at $575.00 per share.

Was the ISRG insider sale under a 10b5-1 plan?

Yes. The sales were made pursuant to a Rule 10b5-1 trading plan that expires on December 10, 2025.

How many ISRG shares does the executive own after the transactions?

He directly owned 5,758 common shares after the reported transactions.

What were the option exercise prices for ISRG shares?

Options were exercised at $229.39 for 1,298 shares and $208.90 for 2,202 shares.

What ISRG derivative holdings remain after the transactions?

Remaining non-qualified stock options total 2,115 and 6,602 shares from prior grants, per the vesting schedules.

What sale price did the ISRG shares fetch?

The reported sales were executed at $575.00 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Brian Edward

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Digital Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		M(1)		1,298	A	$229.39	7,056	D
Common Stock	11/10/2025		S(1)		1,298	D	$575	5,758	D
Common Stock	11/10/2025		M(1)		2,202	A	$208.9	7,960	D
Common Stock	11/10/2025		S(1)		2,202	D	$575	5,758	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$208.9	11/10/2025		M(1)			2,202	(2)	08/28/2029	Common Stock	2,202	$0.0	2,115	D
Non-Qualified Stock Option (right to buy)	$229.39	11/10/2025		M(1)			1,298	(3)	02/27/2030	Common Stock	1,298	$0.0	6,602	D

Explanation of Responses:

1. These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 10, 2025.

2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

3. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Thanh Nhan Phan For: Brian Miller	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.